The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...

Cancer survivors visit the Fight Colorectal Cancer "United in Blue" flag installation on the National Mall to spotlight the ...

Solid tumors, prevalent across various systems such as the respiratory, digestive, urinary, and gynecologic systems, constitute a significant challenge in adult oncology. These tumors are ...

Research from the University of Warwick suggests that many AI systems may be using visual shortcuts rather than true biology, and may be too unreliable for real-world patient care.

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

Braftovi plus Erbitux and FOLFIRI improved progression-free survival in untreated BRAF V600E metastatic colorectal cancer in the phase 3 BREAKWATER trial. A targeted treatment that includes Braftovi ...